Nordhealth Past Earnings Performance
Past criteria checks 0/6
Nordhealth's earnings have been declining at an average annual rate of -62.3%, while the Healthcare Services industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 28.5% per year.
Earnings growth rate
EPS growth rate
|Healthcare Services Industry Growth||17.1%|
|Revenue growth rate||28.5%|
|Return on equity||-15.2%|
|Next Earnings Update||14 Nov 2023|
Recent past performance updates
Earnings and Revenue History
|Date||Revenue||Earnings||G+A Expenses||R&D Expenses|
|30 Jun 23||34||-14||3||0|
|31 Mar 23||33||-15||3||0|
|31 Dec 22||31||-14||3||0|
|30 Sep 22||29||-12||1||0|
|30 Jun 22||27||-10||2||0|
|31 Mar 22||24||-8||1||0|
|31 Dec 21||20||-5||1||0|
|30 Sep 21||18||-2||-1||0|
|30 Jun 21||15||0||-2||0|
|31 Mar 21||13||2||0||0|
|31 Dec 20||13||2||0||0|
|31 Dec 19||8||-1||0||0|
|31 Dec 18||5||-1||0||0|
Quality Earnings: NORDH is currently unprofitable.
Growing Profit Margin: NORDH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: NORDH is unprofitable, and losses have increased over the past 5 years at a rate of 62.3% per year.
Accelerating Growth: Unable to compare NORDH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NORDH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.8%).
Return on Equity
High ROE: NORDH has a negative Return on Equity (-15.24%), as it is currently unprofitable.